K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.
暂无分享,去创建一个
S. Rodenhuis | O. Dalesio | C. Meijer | S. Wagenaar | R. Slebos | J. Bos | R. Slebos | N. van Zandwijk | W. Mooi | C. Meijer | J. Stam | R J Slebos | R E Kibbelaar | O Dalesio | A Kooistra | J Stam | C J Meijer | S S Wagenaar | R G Vanderschueren | N van Zandwijk | W J Mooi | R. Kibbelaar | R. Vanderschueren | R. Kibbelaar | A. Kooistra | A. Kooistra | Jacob Stam
[1] S. Rodenhuis,et al. Recurrent breast cancer and an adenocarcinoma of the lung occurring in one patient: c-myc oncogene amplification and K-ras codon 12 point mutation as tumour markers. , 1988, European journal of cancer & clinical oncology.
[2] S. Hirohashi,et al. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre‐B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice. , 1987, The EMBO journal.
[3] Sobin Lh. The World Health Organization's Histological Classification of Lung Tumors: a comparison of the first and second editions. , 1982 .
[4] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[5] S. Rodenhuis,et al. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. , 1987, The New England journal of medicine.
[6] D. Shibata,et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.
[7] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[8] G. Bepler,et al. Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.
[9] M. Sklar. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. , 1988, Science.
[10] C. Harris,et al. Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation. , 1988, Oncogene research.
[11] Henry A. Erlich,et al. Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes , 1986, Nature.
[12] A. Pellicer,et al. Differential expression of the ras gene family in mice , 1987, Molecular and cellular biology.
[13] J. Gralow,et al. Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. , 1986, Cancer research.
[14] A. Pellicer,et al. Mutational activation of oncogenes in animal model systems of carcinogenesis. , 1987, Mutation research.
[15] J. L. Bos,et al. ras oncogene activation in human ovarian carcinoma. , 1988, Oncogene.
[16] Cori Bargmann,et al. Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene , 1984, Molecular and cellular biology.
[17] N. Lemoine,et al. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. , 1989, Oncogene.
[18] G. Fleuren,et al. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. , 1988, Nucleic acids research.
[19] B. Vogelstein,et al. Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.
[20] S. Rodenhuis,et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.
[21] William E. Grizzle,et al. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis , 1987, Nature.
[22] M. Sklar. Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes. , 1988, Cancer research.
[23] J. Bos,et al. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. , 1986, Gene.